Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $510

Author: Benzinga Newsdesk | July 23, 2024 08:03am
Barclays analyst Matt Miksic maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and raises the price target from $490 to $510.

Posted In: ISRG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist